News for AWAKN LIFE SCIENCES CORP. (AWKN.NE)

Awakn Life Sciences Corp. (AWKNF) has completed its acquisition by Solvonis Therapeutics plc (SVNS). Shareholders will receive 46.67 Solvonis shares for

Over 99% of Awakn Life Sciences (CSE: AWKN, OTC: AWKNF) shareholders approved the acquisition by Solvonis Therapeutics (LSE: SVNS). The final court appr

Solvonis Therapeutics PLC to acquire all outstanding shares of Awakn Life Sciences Corp. (AWKNF). 1,565,404 shares, representing 3.65% of AWKNF's outsta

Canada has licensed Optimi Health to export psilocybin and MDMA to Australia, marking a significant step in the medical psychedelics market.

Canada has licensed Optimi Health to export psychedelics to Australia, a milestone in the growth of medical psychedelic drugs. Read on.

Effective immediately, Awakn Life Sciences Corp. will be reinstated for trading. The Company has rectified the situation that gave rise to the suspension. ...

Awakn Life Sciences Corp. , a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder , announces that, it...

The common shares of Awakn Life Sciences Corp. have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date. ...

Awakn Life Sciences Corp. , a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder , is pleased to announce...

February 9, 2024 (Investorideas.com Newswire) The common shares of Awakn Life Sciences Corp. have been approved for listing on the CSE. Listing and disclosure ...

Toronto, Ontario - January 24, 2024 (Newsfile Corp.) (Investorideas.com Newswire) Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a ...

Awakn Life Sciences Corp. , a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder , is pleased to announce...

Awakn Life Sciences Corp.  , a clinical-stage biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder , shares a corporate update on recent...